These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35510373)

  • 1. A novel oncolytic virus induces a regional cytokine storm and safely eliminates malignant ascites of colon cancer.
    Dong S; Liu B; Hu S; Guo F; Zhong Y; Cai Q; Zhang S; Qian Y; Wang J; Zhou F
    Cancer Med; 2022 Nov; 11(22):4297-4309. PubMed ID: 35510373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer.
    Lee YS; Lee WS; Kim CW; Lee SJ; Yang H; Kong SJ; Ning J; Yang KM; Kang B; Kim WR; Chon HJ; Kim C
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33199510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
    Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
    Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
    [No Abstract]   [Full Text] [Related]  

  • 4. SIRPα antibody combined with oncolytic virus OH2 protects against tumours by activating innate immunity and reprogramming the tumour immune microenvironment.
    Kong D; Yang Z; Li G; Wu Q; Gu Z; Wan D; Zhang Q; Zhang X; Cheng S; Liu B; Zhang K; Zhang W
    BMC Med; 2022 Oct; 20(1):376. PubMed ID: 36310169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell transcriptomics of peripheral blood reveals anti-tumor systemic immunity induced by oncolytic virotherapy.
    Wu Q; Hu X; Zhang X; Kong D; Yang Z; Li G; Gu Z; Zhang Q; Wan D; Cheng S; Liu B; Zhang K; Zhang W
    Theranostics; 2022; 12(17):7371-7389. PubMed ID: 36438484
    [No Abstract]   [Full Text] [Related]  

  • 6. Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial.
    Zhang B; Huang J; Tang J; Hu S; Luo S; Luo Z; Zhou F; Tan S; Ying J; Chang Q; Zhang R; Geng C; Wu D; Gu X; Liu B
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33837053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OH2 oncolytic virus: A novel approach to glioblastoma intervention through direct targeting of tumor cells and augmentation of anti-tumor immune responses.
    Zheng Y; Wang X; Ji Q; Fang A; Song L; Xu X; Lin Y; Peng Y; Yu J; Xie L; Chen F; Li X; Zhu S; Zhang B; Zhou L; Yu C; Wang Y; Wang L; Hu H; Zhang Z; Liu B; Wu Z; Li W
    Cancer Lett; 2024 May; 589():216834. PubMed ID: 38537773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade.
    Zuo S; Wei M; Xu T; Kong L; He B; Wang S; Wang S; Wu J; Dong J; Wei J
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34949694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice.
    Thomas ED; Meza-Perez S; Bevis KS; Randall TD; Gillespie GY; Langford C; Alvarez RD
    J Ovarian Res; 2016 Oct; 9(1):70. PubMed ID: 27784340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Effects of M51R Vesicular Stomatitis Virus Treatment of Carcinomatosis From Colon Cancer.
    Day GL; Bryan ML; Northrup SA; Lyles DS; Westcott MM; Stewart JH
    J Surg Res; 2020 Jan; 245():127-135. PubMed ID: 31415934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Safety Evaluation of Oncolytic Herpes Simplex Virus Type 2.
    Wang Y; Zhou X; Wu Z; Hu H; Jin J; Hu Y; Dong Y; Zou J; Mao Z; Shi X; Huo Y; Lyu J; Fang Z; Zhang W; Zhu Y; Li B; Liu B
    Hum Gene Ther; 2019 May; 30(5):651-660. PubMed ID: 30499341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT).
    Zuo S; Wei M; He B; Chen A; Wang S; Kong L; Zhang Y; Meng G; Xu T; Wu J; Yang F; Zhang H; Wang S; Guo C; Wu J; Dong J; Wei J
    EBioMedicine; 2021 Feb; 64():103240. PubMed ID: 33581644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic adenovirus in treating malignant ascites: A phase II trial and longitudinal single-cell study.
    Zhang Y; Qian L; Chen K; Gu S; Meng Z; Wang J; Li Y; Wang P
    Mol Ther; 2024 Jun; 32(6):2000-2020. PubMed ID: 38659226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOCS4 expressed by recombinant HSV protects against cytokine storm in a mouse model.
    Ren S; Chen X; Huang R; Zhou GG; Yuan Z
    Oncol Rep; 2019 Mar; 41(3):1509-1520. PubMed ID: 30569160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining IL-10 and Oncolytic Adenovirus Demonstrates Enhanced Antitumor Efficacy Through CD8
    Chen D; Huang L; Zhou H; Zhang Y
    Front Immunol; 2021; 12():615089. PubMed ID: 33717103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment.
    Nakatake M; Kuwano N; Kaitsurumaru E; Kurosaki H; Nakamura T
    Mol Ther; 2021 May; 29(5):1782-1793. PubMed ID: 33348052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy.
    Bai FL; Yu YH; Tian H; Ren GP; Wang H; Zhou B; Han XH; Yu QZ; Li DS
    Cancer Biol Ther; 2014 Sep; 15(9):1226-38. PubMed ID: 24971746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer.
    Lee SJ; Yang H; Kim WR; Lee YS; Lee WS; Kong SJ; Lee HJ; Kim JH; Cheon J; Kang B; Chon HJ; Kim C
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response.
    Zhang Y; Qian L; Chen K; Gu S; Wang J; Meng Z; Li Y; Wang P
    Mol Ther Oncolytics; 2022 Jun; 25():31-42. PubMed ID: 35399603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivated Sendai virus strain Tianjin, a novel genotype of Sendai virus, inhibits growth of murine colon carcinoma through inducing immune responses and apoptosis.
    Shi L; Chen J; Zhong Q; Li M; Geng P; He J; Han Z; Sheng M; Tang H
    J Transl Med; 2013 Sep; 11():205. PubMed ID: 24007528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.